NYSE:CEChemicals
Is Celanese’s Q2 Margin Squeeze Amid Rising Sales Altering The Investment Case For Celanese (CE)?
Celanese Corporation reported past second-quarter 2026 results, with sales rising to US$2,752 million from US$2,532 million a year earlier, while net income fell to US$125 million from US$197 million and diluted earnings per share from continuing operations declined to US$1.15 from US$1.89.
The combination of higher revenue but weaker profitability highlights pressure on margins despite top-line growth, raising questions about cost efficiency and earnings quality within Celanese’s business...